XML 19 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Marketable Securities
3 Months Ended
Jun. 24, 2017
Marketable Securities [Abstract]  
Marketable Securities
Marketable Securities

The Company’s investments that have original maturities greater than 90 days have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the consolidated condensed balance sheet as short- and long-term marketable securities, as appropriate.

The following table is a summary of available-for-sale securities at June 24, 2017 (in thousands):
As of June 24, 2017
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities
$
133,471

 
$
76

 
$
(85
)
 
$
133,462

Non-US government securities
11,816

 
2

 
(9
)
 
11,809

Certificates of deposit
500

 

 

 
500

Agency discount notes
459

 
1

 

 
460

Total securities
$
146,246

 
$
79

 
$
(94
)
 
$
146,231


    
The Company typically invests in highly-rated securities with original maturities generally ranging from one to three years. The Company's specifically identified gross unrealized loss of $94 thousand related to securities with total amortized cost of approximately $82.9 million at June 24, 2017.  No securities have been in a continuous unrealized loss position for more than 12 months as of June 24, 2017. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management.  When evaluating an investment for other-than-temporary impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of June 24, 2017, the Company does not consider any of its investments to be other-than-temporarily impaired.   

The following table is a summary of available-for-sale securities at March 25, 2017 (in thousands):
໿
໿
As of March 25, 2017
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities
33,350

 
$

 
$
(20
)
 
$
33,330

Commercial paper
66,518

 

 
(35
)
 
66,483

Total securities
$
99,868

 
$

 
$
(55
)
 
$
99,813



The Company’s specifically identified gross unrealized losses of $55 thousand related to securities with total amortized cost of approximately $99.9 million at March 25, 2017. Four securities had been in a continuous loss position for more than 12 months as of March 25, 2017 The gross unrealized loss on these securities was less than one percent of the position value.  The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management.  When evaluating an investment for other-than-temporary impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of March 25, 2017, the Company did not consider any of its investments to be other-than-temporarily impaired.  

The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):
໿

June 24, 2017
 
March 25, 2017

Amortized
 
Estimated
 
Amortized
 
Estimated

Cost
 
Fair Value
 
Cost
 
Fair Value
Within 1 year
$
11,388

 
$
11,380

 
$
99,868

 
$
99,813

After 1 year
134,858

 
134,851

 

 

Total
$
146,246

 
$
146,231

 
$
99,868

 
$
99,813